IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 6, 2014, Pages 1422-1432.e11

  Li, Dong ^a   Guabiraba, Rodrigo ^a,b   Besnard, Anne Gaëlle ^a   Komai Koma, Mousa ^c   Jabir, Majid S ^a,d   Zhang, Li ^e   Graham, Gerard J ^a   Kurowska Stolarska, Mariola ^a   Liew, Foo Y ^a,f   McSharry, Charles ^a   Xu, Damo ^a,e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UR1282   (France)

^c UMM AL QURA UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF TECHNOLOGY   (Iraq)

^e INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

alternatively activated macrophages; IL 33; lung fibrosis; type 2 innate lymphoid cells

Indexed keywords

BLEOMYCIN; COLLAGEN; INTERLEUKIN 13; INTERLEUKIN 33; TRANSFORMING GROWTH FACTOR BETA1; IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; CYTOMETRY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; HISTOLOGY; INFLAMMATORY CELL; LAVAGE CYTOLOGY; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM CELL; LUNG FIBROSIS; LUNG PARENCHYMA; LYMPHOCYTE; LYMPHOID CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TYPE 2 INNATE LYMPHOID CELL; WILD TYPE; ANIMAL; C57BL MOUSE; FIBROSIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LUNG ALVEOLUS MACROPHAGE; PATHOLOGY;

ANIMALS; FIBROSIS; INTERLEUKIN-13; INTERLEUKIN-33; INTERLEUKINS; LUNG; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84919866420     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.05.011     Document Type: Article

References (46)

1. M.A. Mouratis, and V. Aidinis Modeling pulmonary fibrosis with bleomycin Curr Opin Pulm Med 17 2011 355 361
2. H. Umezawa, M. Ishizuka, K. Maeda, and T. Takeuchi Studies on bleomycin Cancer 20 1967 891 895
3. L.M. Mir, O. Tounekti, and S. Orlowski Bleomycin: revival of an old drug Gen Pharmacol 27 1996 745 748
4. T.A. Wynn, and T.R. Ramalingam Mechanisms of fibrosis: therapeutic translation for fibrotic disease Nat Med 18 2012 1028 1040
5. C.J. Scotton, and R.C. Chambers Molecular targets in pulmonary fibrosis: the myofibroblast in focus Chest 132 2007 1311 1321
6. S. Gordon Alternative activation of macrophages Nat Rev Immunol 3 2003 23 35
7. S.K. Biswas, and A. Mantovani Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm Nat Immunol 11 2010 889 896
8. T. Hoshino, M. Okamoto, Y. Sakazaki, S. Kato, H.A. Young, and H. Aizawa Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice Am J Respir Cell Mol Biol 41 2009 661 670
9. I.G. Luzina, P. Kopach, V. Lockatell, P.H. Kang, A. Nagarsekar, and A.P. Burke Interleukin-33 potentiates bleomycin-induced lung injury Am J Respir Cell Mol Biol 49 2013 999 1008
10. E.S. Baekkevold, M. Roussigne, T. Yamanaka, F.E. Johansen, F.L. Jahnsen, and F. Amalric Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules Am J Pathol 163 2003 69 79
11. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, and T.K. McClanahan IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
12. M. Pichery, E. Mirey, P. Mercier, E. Lefrancais, A. Dujardin, and N. Ortega Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain J Immunol 188 2012 3488 3495
13. E. Lefrancais, S. Roga, V. Gautier, A. Gonzalez-de-Peredo, B. Monsarrat, and J.P. Girard IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G Proc Natl Acad Sci U S A 109 2012 1673 1678
14. V. Carriere, L. Roussel, N. Ortega, D.A. Lacorre, L. Americh, and L. Aguilar IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci U S A 104 2007 282 287
15. C. Moussion, N. Ortega, and J.P. Girard The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "alarmin"? PLoS One 3 2008 e3331
16. D. Xu, H.R. Jiang, P. Kewin, Y. Li, R. Mu, and A.R. Fraser IL-33 exacerbates antigen-induced arthritis by activating mast cells Proc Natl Acad Sci U S A 105 2008 10913 10918
17. H. Spits, and J.P. Di Santo The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling Nat Immunol 12 2011 21 27
18. K. Oboki, T. Ohno, N. Kajiwara, K. Arae, H. Morita, and A. Ishii IL-33 is a crucial amplifier of innate rather than acquired immunity Proc Natl Acad Sci U S A 107 2010 18581 18586
19. M. Kurowska-Stolarska, B. Stolarski, P. Kewin, G. Murphy, C.J. Corrigan, and S. Ying IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation J Immunol 183 2009 6469 6477
20. M. Kurowska-Stolarska, P. Kewin, G. Murphy, R.C. Russo, B. Stolarski, and C.C. Garcia IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4 J Immunol 181 2008 4780 4790
21. M. Komai-Koma, F. Brombacher, P.N. Pushparaj, B. Arendse, C. McSharry, and J. Alexander Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice Allergy 67 2012 1118 1126
22. N.E. Humphreys, D. Xu, M.R. Hepworth, F.Y. Liew, and R.K. Grencis IL-33, a potent inducer of adaptive immunity to intestinal nematodes J Immunol 180 2008 2443 2449
23. N. Van Rooijen, and A. Sanders Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J Immunol Methods 174 1994 83 93
24. T. Thepen, N. Van Rooijen, and G. Kraal Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice J Exp Med 170 1989 499 509
25. C.E. Daniels, M.C. Wilkes, M. Edens, T.J. Kottom, S.J. Murphy, and A.H. Limper Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis J Clin Invest 114 2004 1308 1316
26. A.B. Molofsky, J.C. Nussbaum, H.E. Liang, S.J. Van Dyken, L.E. Cheng, and A. Mohapatra Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages J Exp Med 210 2013 535 549
27. D.R. Neill, S.H. Wong, A. Bellosi, R.J. Flynn, M. Daly, and T.K. Langford Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity Nature 464 2010 1367 1370
28. R.J. Salmond, A.S. Mirchandani, A.G. Besnard, C.C. Bain, N.C. Thomson, and F.Y. Liew IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin J Allergy Clin Immunol 130 2012 1159 1166.e6
29. A. Rot, and U.H. von Andrian Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells Annu Rev Immunol 22 2004 891 928
30. R.M. Strieter, B.N. Gomperts, and M.P. Keane The role of CXC chemokines in pulmonary fibrosis J Clin Invest 117 2007 549 556
31. E. Lefrancais, and C. Cayrol Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members Eur Cytokine Netw 23 2012 120 127
32. Y. Ohtsuka, J. Lee, D.S. Stamm, and I.R. Sanderson MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine Gut 49 2001 526 533
33. I. Gur, R. Or, M.J. Segel, M. Shriki, G. Izbicki, and R. Breuer Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice Exp Lung Res 26 2000 521 534
34. L. Roussel, R. Farias, and S. Rousseau IL-33 is expressed in epithelia from patients with cystic fibrosis and potentiates neutrophil recruitment J Allergy Clin Immunol 131 2013 913 916
35. K. Yanaba, A. Yoshizaki, Y. Asano, T. Kadono, and S. Sato Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis Clin Rheumatol 30 2011 825 830
36. M.A. Sedhom, M. Pichery, J.R. Murdoch, B. Foligne, N. Ortega, and S. Normand Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice Gut 62 2013 1714 1723
37. X. Zhiguang, C. Wei, R. Steven, D. Wei, Z. Wei, and M. Rong Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice Immunol Lett 131 2010 159 165
38. M. Kurowska-Stolarska, B. Stolarski, P. Kewin, G. Murphy, C.J. Corrigan, and S. Ying IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation J Immunol 183 2009 6469 6477
39. M. Kurowska-Stolarska, P. Kewin, G. Murphy, R.C. Russo, B. Stolarski, and C.C. Garcia IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4 J Immunol 181 2008 4780 4790
40. M. Komai-Koma, D. Xu, Y. Li, A.N. McKenzie, I.B. McInnes, and F.Y. Liew IL-33 is a chemoattractant for human Th2 cells Eur J Immunol 37 2007 2779 2786
41. N. Van Rooijen, and A. Sanders Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J Immunol Methods 174 1994 83 93
42. C. Qiu, Y. Li, M. Li, X. Liu, C. McSharry, and D. Xu Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice Immunology 138 2013 76 82
43. R.C. Russo, R. Guabiraba, C.C. Garcia, L.S. Barcelos, E. Roffe, and A.L. Souza Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis Am J Respir Cell Mol Biol 40 2009 410 421
44. R.J. Salmond, A.S. Mirchandani, A.G. Besnard, C.C. Bain, N.C. Thomson, and F.Y. Liew IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin J Allergy Clin Immunol 130 2012 1159 1166.e6
45. C.E. Daniels, M.C. Wilkes, M. Edens, T.J. Kottom, S.J. Murphy, and A.H. Limper Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis J Clin Invest 114 2004 1308 1316
46. L. Xu, L. Bao, W. Deng, H. Zhu, T. Chen, and Q. Lv The mouse and ferret models for studying the novel avian-origin human influenza A (H7N9) virus Virol J 10 2013 253